• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hollow microspheres for gastroretentive floating- pulsatile drug delivery: preparation and in vitro evaluation.用于胃滞留漂浮-脉冲给药的中空微球:制备与体外评价
Adv Pharm Bull. 2011;1(2):55-61. doi: 10.5681/apb.2011.008. Epub 2011 Dec 15.
2
Floating-pulsatile release multiparticulate system for chronopharmacotherapy: effect of some hydrophobic additives on the buoyancy and release behavior of particles.用于时辰治疗的漂浮-脉冲释放多颗粒系统:某些疏水添加剂对颗粒浮力和释放行为的影响。
Drug Res (Stuttg). 2014 Jan;64(1):10-6. doi: 10.1055/s-0033-1349838. Epub 2013 Aug 15.
3
In-vitro characterization of gastroretentive microballoons prepared by the emulsion solvent diffusion method.通过乳液溶剂扩散法制备的胃滞留微球的体外特性研究
J Adv Pharm Technol Res. 2010 Jan;1(1):56-67.
4
Low density multiparticulate system for pulsatile release of meloxicam.用于美洛昔康脉冲释放的低密度多颗粒系统。
Int J Pharm. 2006 Apr 26;313(1-2):150-8. doi: 10.1016/j.ijpharm.2006.02.001. Epub 2006 Mar 15.
5
Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.通过乳液溶剂扩散法制备的中空微球(微球囊)浮力测定的物理化学性质。
Eur J Pharm Biopharm. 2003 May;55(3):297-304. doi: 10.1016/s0939-6411(03)00003-1.
6
In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.乳液溶剂扩散法制备的中空微球(微球囊)的漂浮及释药行为的体外评价
Eur J Pharm Biopharm. 2004 Mar;57(2):235-43. doi: 10.1016/S0939-6411(03)00185-1.
7
Preparation and evaluation of sustained release microballoons of propranolol.制备及评价普萘洛尔缓释微球。
Daru. 2011;19(3):193-201.
8
Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine.法莫替丁胃内滞留型漂浮多颗粒给药系统的优化研究
Drug Dev Ind Pharm. 2008 Nov;34(11):1201-8. doi: 10.1080/03639040802005016.
9
Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach.载盐酸法莫替丁空心微球(微球)的漂浮控释给药系统在胃部。
Curr Drug Deliv. 2010 Jan;7(1):93-7. doi: 10.2174/156720110790396436.
10
Hollow microspheres for use as a floating controlled drug delivery system in the stomach.用作胃部漂浮控释给药系统的中空微球。
J Pharm Sci. 1992 Feb;81(2):135-40. doi: 10.1002/jps.2600810207.

引用本文的文献

1
Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications.胃滞留技术与控释策略相结合:解决口服药物生物利用度和患者依从性问题的有效方案。
Pharmaceutics. 2021 Sep 30;13(10):1591. doi: 10.3390/pharmaceutics13101591.
2
Dramatic improvement in dissolution rate of albendazole by a simple, one-step, industrially scalable technique.通过一种简单的、一步式的、可在工业上规模化的技术,阿苯达唑的溶出速率得到显著提高。
Res Pharm Sci. 2016 Dec;11(6):435-444. doi: 10.4103/1735-5362.194868.
3
Pentoxifylline Loaded Floating Microballoons: Design, Development and Characterization.己酮可可碱载药漂浮微球:设计、开发与表征
J Pharm (Cairo). 2013;2013:107291. doi: 10.1155/2013/107291. Epub 2013 May 9.
4
Chronomodulated drug delivery system of urapidil for the treatment of hypertension.用于治疗高血压的乌拉地尔时辰调制给药系统。
Int J Pharm Investig. 2015 Apr-Jun;5(2):107-13. doi: 10.4103/2230-973X.153389.

本文引用的文献

1
Development and evaluation of dual controlled release microballoons containing riboflavin and citric acid: in vitro and in vivo evaluation.研制并评价含核黄素和柠檬酸的双控释微球:体外与体内评价。
J Microencapsul. 2011;28(5):442-54. doi: 10.3109/02652048.2011.576788. Epub 2011 May 10.
2
pH-sensitive Eudragit nanoparticles for mucosal drug delivery.pH 敏感型 Eudragit 纳米粒用于黏膜给药剂型。
Int J Pharm. 2011 Jan 17;403(1-2):262-7. doi: 10.1016/j.ijpharm.2010.10.032. Epub 2010 Oct 31.
3
Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.用于胃滞留漂浮给药的瑞格列奈硅酸钙基微球:制备与体外表征
J Control Release. 2005 Oct 3;107(2):300-9. doi: 10.1016/j.jconrel.2005.06.007.
4
Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.用于时辰药理学治疗的含硝苯地平的缓释包衣片芯。
Int J Pharm. 2004 Aug 6;280(1-2):103-11. doi: 10.1016/j.ijpharm.2004.05.004.
5
Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms.胃滞留剂型的药代动力学和药效学方面
Int J Pharm. 2004 Jun 11;277(1-2):141-53. doi: 10.1016/j.ijpharm.2003.09.047.
6
THE FLOW PROPERTIES OF MAGNESIA.氧化镁的流动特性。
J Pharm Pharmacol. 1964 Nov;16:705-16. doi: 10.1111/j.2042-7158.1964.tb07394.x.
7
Circadian rhythms in RA.类风湿关节炎中的昼夜节律
Ann Rheum Dis. 2003 Jul;62(7):593-6. doi: 10.1136/ard.62.7.593.
8
Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.通过乳液溶剂扩散法制备的中空微球(微球囊)浮力测定的物理化学性质。
Eur J Pharm Biopharm. 2003 May;55(3):297-304. doi: 10.1016/s0939-6411(03)00003-1.
9
Characterization of piroxicam crystal modifications.吡罗昔康晶体变体的表征
Int J Pharm. 2003 Apr 30;256(1-2):3-15. doi: 10.1016/s0378-5173(03)00057-7.
10
Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam.缓释制剂可避免地尔硫䓬与咪达唑仑之间的药物相互作用。
J Pharm Sci. 2003 Apr;92(4):790-7. doi: 10.1002/jps.10336.

用于胃滞留漂浮-脉冲给药的中空微球:制备与体外评价

Hollow microspheres for gastroretentive floating- pulsatile drug delivery: preparation and in vitro evaluation.

作者信息

Maghsoodi Maryam, Hemati Elham, Qadermazi Bahram, Yari Zahra

机构信息

Drug applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2011;1(2):55-61. doi: 10.5681/apb.2011.008. Epub 2011 Dec 15.

DOI:10.5681/apb.2011.008
PMID:24312757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3845978/
Abstract

PURPOSE

A multiparticular floating-pulsatile drug delivery system was developed for time and site specific drug release of piroxicam. A blend of floating and pulsatile principles of drug delivery system would have the advantage that a drug can be released in the upper GI tract after a definite time period.

METHODS

Hollow microspheres were prepared by the emulsion solvent diffusion method using Eudragit S as an enteric acrylic polymer with piroxicam at various polymer/drug ratios in a mixture of dichloromethane and ethanol. Developed formulations were evaluated for yield, encapsulation efficiency, particle size, shape, apparent density, buoyancy studies and dissolution studies.

RESULTS

The obtained microballoons were spherical with no major surface irregularity and mean particle size ranging from 250 to 380 for different batches. Formulations show a slight amount of relaese ranging from 0.7 to 11% in acidic medium (SGF) with complete release of drug in simulated intestinal fluid (SIF) in less than 3 h. Encapsulation efficiency of different formulations varied from 90 to 98%. The optimum loading amount of drug in the particles was found to impart suitable floatable properties to the microballoons. With increasing polymer/drug ratio, buancy of the microballoons increases accompanied by simultaneous reduction of apparent particle density.

CONCLUSION

A pulsatile release of piroxicam was demonstrated by a simple drug delivery system which could be useful in chronopharmacotherapy of rheumatoid arthritis.

摘要

目的

开发一种多微粒漂浮-脉冲式药物递送系统,用于吡罗昔康的定时和定位药物释放。药物递送系统的漂浮和脉冲原理相结合具有这样的优势,即药物可在特定时间段后在上消化道释放。

方法

采用乳液溶剂扩散法,以Eudragit S作为肠溶丙烯酸聚合物,在二氯甲烷和乙醇的混合物中,按照不同的聚合物/药物比例,制备含吡罗昔康的中空微球。对所开发的制剂进行产率、包封率、粒径、形状、表观密度、漂浮性研究和溶出度研究。

结果

所获得的微球呈球形,表面无明显不规则,不同批次的平均粒径在250至380之间。制剂在酸性介质(模拟胃液)中的释放量为0.7%至11%,在模拟肠液中药物在不到3小时内完全释放。不同制剂的包封率在90%至98%之间。发现颗粒中药物的最佳负载量赋予微球合适的漂浮性能。随着聚合物/药物比例的增加,微球的漂浮性增加,同时表观颗粒密度降低。

结论

一种简单的药物递送系统证明了吡罗昔康的脉冲释放,这可能对类风湿性关节炎的时辰药物治疗有用。